Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Apr 14;13(14):2037-43.
doi: 10.3748/wjg.v13.i14.2037.

Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?

Affiliations
Review

Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?

Natale D'Alessandro et al. World J Gastroenterol. .

Abstract

Primary hepatocellular carcinoma (HCC) is a quite frequent tumor which results in high mortality and most often exhibits a poor response to present drug therapies. Clearly, a thorough understanding of the biological bases of this malignancy might suggest new strategies for its treatment. Here we examine the evidences that both "pharmacological" mechanisms (e.g. drug transporter or detoxification enzyme over-expression) and alterations in other critical factors, including the IAPs (Inhibitory of Apoptosis Proteins), involved in enhancement of cell survival and proliferation may determine the therapeutic resistance of HCC; we also underline the possible role in the process of the activation of transcription factors, like NF-kappaB, capable of contemporaneously up-regulating the mechanisms discussed. On this basis, we finally comment on the possible use of natural multi-targeted antitumoral agents like plant polyphenols to achieve sensitization to treatments in HCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Some of the principal tumor targets of polyphenols discussed in the text. The agents may directly interfere with the affected molecules (e.g. Telomerase, COX-2 and P-gp) and/or influence their activity or expression due to modifications in an upstream regulatory signal or in factors (e.g. NF-κB) which regulate gene transcription.

References

    1. D'Alessandro N, Flugy A, Borsellino N, Travali S. Biology versus pharmacology in drug resistance. Oncol Rep. 1997;4:207–210.
    1. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol. 1999;17:2941–2953. - PubMed
    1. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998;17:3247–3259. - PubMed
    1. Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D'Alessandro N. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins) Cancer Lett. 2002;180:91–101. - PubMed
    1. Falkson JM, MacIntyre JM, Moertel CG. Primary liver cancer. Cancer. 1994;54:977–980. - PubMed

MeSH terms